Evidence map›Paper›PMID 32100599›Full record

ArticleLeukemia & lymphoma2020

Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy.

Rory M Shallis, Maximilian Stahl, Wei Wei, Pau Montesinos, Etienne Lengline, Judith Neukirchen, Vijaya R Bhatt, Mikkael A Sekeres, Amir T Fathi, Heiko Konig and 26 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia & lymphoma, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. [Analysis of risk factors for early death in hyperleukocytic acute leukemia].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2025
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Rory M ShallisDepartment of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-8542-2944
Maximilian StahlDepartment of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
Wei WeiDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
Pau MontesinosCIBERONC, Instituto Carlos III, Madrid, Spain.ORCID 0000-0002-3275-5593
Etienne LenglineHematology Department, Saint-Louis Hospital AP-HP, Paris, France.
Judith NeukirchenDepartment of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
Vijaya R BhattFred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
Mikkael A SekeresLeukemia Program, Cleveland Clinic, Cleveland, OH, USA.
Amir T FathiMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
Heiko KonigIndiana University Simon Cancer Center, Indianapolis, IN, USA.
Selina LugerAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Irum KhanUniversity of Illinois Cancer Center, Chicago, IL, USA.
Gail J RobozWeill Cornell Medicine, The New York Presbyterian Hospital, New York, NY, USA.
Thomas CluzeauCHU of Nice, Hematology Department, Cote d'Azur University, Nice, France.
David Martínez-CuadronCIBERONC, Instituto Carlos III, Madrid, Spain.
Emmanuel RaffouxHematology Department, Saint-Louis Hospital AP-HP, Paris, France.
Ulrich GermingDepartment of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
Jayadev Manikkam UmakanthanUniversity of North Carolina Physician Network, Rocky Mount, NC, USA.
Sudipto MukherejeLeukemia Program, Cleveland Clinic, Cleveland, OH, USA.
Andrew M BrunnerMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
Adam MillerIndiana University Simon Cancer Center, Indianapolis, IN, USA.
Christine M McMahonAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0001-9745-9595
Ellen K RitchieWeill Cornell Medicine, The New York Presbyterian Hospital, New York, NY, USA.
Rebeca Rodríguez-VeigaCIBERONC, Instituto Carlos III, Madrid, Spain.
Raphaël ItzyksonHematology Department, Saint-Louis Hospital AP-HP, Paris, France.
Blanca BoludaCIBERONC, Instituto Carlos III, Madrid, Spain.ORCID 0000-0002-1785-5561
Florence RabianCIBERONC, Instituto Carlos III, Madrid, Spain.
Mar TormoUniversity Clinical Hospital, INCLIVA, Valencia, Spain.ORCID 0000-0001-9622-1649
Evelyn Acuña-CruzCIBERONC, Instituto Carlos III, Madrid, Spain.
Emma RabinovichUniversity of Illinois Cancer Center, Chicago, IL, USA.
Brendan YooAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Isabel CanoCIBERONC, Instituto Carlos III, Madrid, Spain.
Nikolai A PodoltsevDepartment of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
Jan Philipp BewersdorfDepartment of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-3352-0902
Steven GoreDepartment of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
Amer M ZeidanDepartment of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI MEGAN C KING · 1985 to 2026
$85.0M
Institutional Career DevelopmentKL2TR002002 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PHILLIPS, SHANE A · 2016 to 2024
$6.8M
CLINICAL SCHOLARS BIOMEDICAL RESEARCH TRAINING PROGRAMT32CA009512 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Ping Chi · 1985 to 2026
$6.3M
NCATS NIH HHS KL2 TR002002NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016359NCI NIH HHS T32 CA009512
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcuteHumansLeukapheresisLeukocytosis

Identifiers

PMID32100599
PMCPMC8273667

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.